BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Poxel and Sumitomo Dainippon Pharma Announce Initiation of Phase III Program for Imeglimin, an Investigational Therapeutic Agent for Type 2 Diabetes, in Japan

  In December 2017, the first patient was included in the TIMES 1 trial, a multicenter, double-blind, placebo-controlled, randomized, monotherapy study in over 200 Japanese patients with type 2 diabetes.

  December 27, 2017

   · 

  7 min read
• Policy

  CStone Files MEK Inhibitor CS3006 for Clinical Trial Approval in Australia

  Preliminary studies have shown that CS3006 demonstrated good pharmacokinetic properties, and has produced promising synergistic activity when combined with an anti-PD-1 antibody in animal models.

  December 27, 2017

   · 

  4 min read
• 

  Policy

  SoCal’s Glaukos Files PMA Bid for iStent Inject Glaucoma Treatment

  The iStent inject is designed to improve aqueous humor outflow into Schlemm’s canal and reduce IOP in glaucoma patients undergoing cataract surgery.

  December 27, 2017

   · 

  7 min read
• Business

  Astrotech Reports Final Results From Fiscal Year 2017 Annual Meeting of Shareholders

  Astrotech reported the final results of its fiscal year 2017 Annual Meeting of Shareholders held on December 7, 2017 and reconvened on December 22, 2017.

  December 27, 2017

   · 

  2 min read
• Deals

  GenScript Biotech Acquires CustomArray to Expand Synthetic Biology Product Portfolio

  Terms of the deal were not disclosed.

  December 27, 2017

   · 

  4 min read
• 

  Business

  SoCal’s Peregrine Names a New CEO, to Change Name to Avid Bioservices

  Dr. Lias succeeds Steven W. King, who resigned as president and chief executive officer of Peregrine to pursue other professional interests.

  December 27, 2017

   · 

  5 min read
• 

  FDA

  FDA Green Lights Anika’s Injectable HA-Based Bone Repair Treatment

  The treatment is indicated for filling bone voids or defects of the skeletal system.

  December 27, 2017

   · 

  6 min read
• Momentum Builds for CanniMed’s Acquisition of Newstrike as Regulators Confirm 105 Day Minimum Deposit Period Should Not Be Shortened

  Aurora’s attempt to reduce the minimum bid period was inappropriate and clearly an attempt to pressure CanniMed shareholders into tendering to the coercive Hostile Bid by unfairly shortening the statutorily required bid period.

  December 27, 2017

   · 

  9 min read
• Angle PLC: Holding(s) in Company on December 27

  Standard form for notification of major holdings.

  December 27, 2017

   · 

  12 min read
• Biotech Beach

  Astute Medical’s Test for AKI Risk Assessment Could Lead to Safer ICU Care

  The study also showed distinct biomarker level increases indicating when major surgery and nonsteroidal anti-inflammatory drugs put patients at risk of AKI.

  December 27, 2017

   · 

  7 min read